Pioneering Clean Air Solutions: An Insightful Interview with Respiray

The air quality we breathe has become a pressing health concern, causing innovative solutions to be more vital than ever. Respiray, a European health tech startup, stands at the forefront of this battle, harnessing cutting-edge technology to offer groundbreaking wearable air purifiers. Founded amidst the global upheaval of the COVID-19 pandemic in 2020, Respiray distinguished itself by developing a device that uses UV-C technology to neutralize harmful viruses in the air. Initial success paved the way for the company’s ambitious mission: to improve the quality of life through access to clean air, free from allergens and pollutants.

With a vision rooted in innovation and well-being, Respiray aims to redefine how the world approaches respiratory health. The launch of their second-generation wearable, the Respiray Wear A+, marks a milestone in their journey. Designed to combat airborne allergies, the device offers a drug-free, side-effect-free solution to millions suffering from common allergens. Through an exhaustive development process involving 117 prototypes and rigorous testing, the company has crafted a product that provides instant relief and embodies the company’s core mission: to be the go-to choice for preventing respiratory issues caused by airborne factors.

In this exclusive interview, we delve into the origins of Respiray, the inspiration behind their products, and the technology that sets them apart. We also explore the impact of their devices on consumers and the industry, backed by scientific evidence and a commitment to sustainability. Respiray shares exciting plans for future developments, underscoring their dedication to advancing respiratory health solutions. Join us as we uncover the story of Respiray, a company truly breathing new life into health technology.

Grit Daily: Can you introduce Respiray and explain the core mission and vision of the company?

Respiray is a European health tech startup that emerged in response to the challenges posed by the COVID-19 pandemic. The company was founded in 2020, and its initial breakthrough product was a wearable air purifier utilizing UV-C technology to combat viruses. The success of this product earned Respiray multiple global awards, including the Financial Times and Seedstars Challenge – Top 30 Health Start-Up 2021, the Healthcare Innovation World Cup 2021, and more.

In 2022, we embarked on a new chapter by developing our second-generation wearable – Respiray Wear A+. This development was driven by our commitment to addressing the concerns of individuals dealing with airborne allergies. After refining 117 prototypes and rigorous testing, we proudly launched Wear A+. This highly effective wearable prevents the inhalation of allergens, providing relief by stopping allergic reactions and significantly enhancing users’ overall quality of life.

At the core of Respiray’s mission is a dedication to improving people’s quality of life by providing easy access to instant clean air. We envision Respiray as the go-to, drug-free choice for preventing respiratory health issues from airborne factors. Our commitment to innovation and well-being propels us forward as we strive to be at the forefront of solutions that positively impact respiratory health on a global scale.

Grit Daily: What inspired the creation of Respiray, and what problem(s) are you aiming to solve with your product?

As 81 million Americans suffer from airborne allergies, Respiray emerges as a game-changing wearable health tech that offers instant drug-free protection with no side effects. Respiray Wear A+ relieves millions of allergy sufferers by preventing them from inhaling allergen particles and avoiding common allergic reactions such as runny nose, sneezing and watery eyes. We enable people to participate in activities they might have avoided due to their allergies, thus enhancing their overall quality of life.

The inspiration for this device stemmed from the personal struggles of the company’s CEO, who encountered health issues from pollen, dust, and pet dander. This led to the idea of creating a device capable of preventing harmful airborne particles from entering one’s airways. Backed by successful clinical trials and laboratory tests, it is a proven and effective drug-free alternative for preventing airborne allergies. 

Grit Daily: Could you explain the technology behind your products and how it differentiates Respiray from other solutions in the market?

Respiray’s technology provides a unique solution by creating a protective barrier against airborne allergens. The idea behind Wear A+ is simple – if you don’t breathe in allergens, you won’t develop an allergic reaction. It’s that simple and proven to work.

Respiray’s Wear A+ features a HEPA filter that captures 99.9% of allergen particles, forming a continuously refreshing ‘shield’ of clean air around the user’s mouth and nose. The key innovation lies in optimizing airflow and speed angle, a process refined through over 117 prototypes. This meticulous optimization ensures that users are effectively shielded from inhaling allergens, averting allergic reactions.

Respiray Wear A+ offers year-round allergy relief at the click of a button. In contrast to traditional remedies on the market, we provide instant, drug-free allergy relief without any side effects. Many existing solutions can be insufficient and may have side effects. Also, standalone air purifiers are not always close enough to prevent people from inhaling allergens. 

Grit Daily: How has the response to your products since launching been from consumers and industries?

Since launching, the response from consumers has been overwhelmingly positive. Many users have shared their transformative experiences, highlighting how Respiray has changed their approach to managing airborne allergies and significantly improved their quality of life. Particularly noteworthy is the feedback from customers who, having relied on traditional allergy medicines for years, express surprise at the effectiveness of Respiray’s new approach in relieving their allergy symptoms. The feedback indicates a genuine shift in their experiences with allergy management through the use of Respiray.

Grit Daily: In terms of health and safety, what evidence or studies can you share that validate the effectiveness of your products?

Wear A+ has been tested by various organizations, including the European Centre for Allergy Research Foundation (ECARF) and the world’s leading testing and certification company SGS in Michigan. Clinical trials carried out by ECARF have concluded that wearing Wear A+ can be recommended medically as a non-drug protection option for people suffering from airborne allergies. Rigorous testing by SGS certifies the HEPA filter’s reliability in capturing 99.9% of airborne particles, such as allergens, viruses, and pollutants. Respiray Wear A+ also meets the standards set by FCC, CE, IC and UKCA.

Grit Daily: What measures does Respiray take to ensure its products’ sustainability and environmental friendliness?

Respiray prioritizes sustainability through fully recyclable, low-impact packaging and a sustainable manufacturing process. We aim to minimize waste by using raw materials efficiently and, when feasible, source components locally to maintain a short supply chain, contributing to a more environmentally friendly approach.

Grit Daily: What future developments or expansions can we expect from Respiray in the coming years?

Respiray is committed to ongoing advancements in respiratory health. The company will persist in improving allergy solutions through continuous research. Simultaneously, they plan to enhance the design and functionality of wearable air purifiers, ensuring they remain at the forefront of innovative solutions. Additionally, Respiray aims to explore versatile applications for Wear A+, the virus protection technology, beyond its primary function, demonstrating a forward-thinking approach to respiratory health solutions.